UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 27, 2009

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-10030

Apple Inc.

(Exact name of Registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

Registrant s telephone number, including area code: (408) 996-1010

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months

(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of

Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer,

accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the

Exchange Act).

Yes No

895,816,758 shares of common stock issued and outstanding as of July 13, 2009

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In millions, except share amounts which are reflected in thousands and per share amounts)

Three Months Ended

Nine Months Ended

June 27,

2009

June 28,

2008

June 27,

2009

June 28,

2008

Net sales

8,337

7,464

26,667

24,584

Cost of sales

5,314

4,864

17,141

16,178

Gross margin

3,023

2,600

9,526

8,406

Operating expenses:

Research and development

341

292

975

811

Selling, general, and administrative

1,010

916

3,086

2,762

Total operating expenses

1,351

1,208

4,061

3,573

Operating income

1,672

1,392

5,465

4,833

Other income and expense

60

118

281

480

Income before provision for income taxes

1,732

1,510

5,746

5,313

Provision for income taxes

503

438

1,707

1,615

Net income

1,229

1,072

4,039

3,698

Earnings per common share:

Basic

1.38

1.21

4.53

4.20

Diluted

1.35

1.19

4.47

4.10

Shares used in computing earnings per share:

Basic

893,712

883,738

891,345

879,753

Diluted

909,160

903,167

904,549

901,028

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In millions, except share amounts)

June 27,

2009

September 27,

2008

ASSETS:

Current assets:

Cash and cash equivalents

5,605

11,875

Short-term marketable securities

18,617

10,236

Accounts receivable, less allowances of $58 and $47, respectively

2,686

2,422

Inventories

380

509

Deferred tax assets

1,731

1,447

Other current assets

6,151

5,822

Total current assets

35,170

32,311

Long-term marketable securities

6,899

2,379

Property, plant and equipment, net

2,653

2,455

Goodwill

207

207

Acquired intangible assets, net

259

285

Other assets

2,952

1,935

Total assets

48,140

39,572

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

4,854

5,520

Accrued expenses

3,338

3,719

Deferred revenue

8,469

4,853

Total current liabilities

16,661

14,092

Deferred revenue non-current

3,667

3,029

Other non-current liabilities

1,924

1,421

Total liabilities

22,252

18,542

Commitments and contingencies

Shareholders equity:

Common stock, no par value; 1,800,000,000 shares authorized; 895,735,210 and

888,325,973 shares issued and outstanding,

respectively

7,957

7,177

Retained earnings

17,878

13,845

Accumulated other comprehensive income

53

Total shareholders equity

25,888

21,030

Total liabilities and shareholders equity

48,140

39,572

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In millions)

Nine Months Ended

June 27,

2009

June 28,

2008

Cash and cash equivalents, beginning of the period

11,875

9,352

Operating Activities:

Net income

4,039

3,698

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation, amortization, and accretion

506

339

Stock-based compensation expense

530

375

Deferred income tax (benefit)/expense

(201

41

Loss on disposition of property, plant and equipment

18

15

Changes in operating assets and liabilities:

Accounts receivable, net

(264

34

Inventories

129

(199

Other current assets

(298

(100

Other assets

(816

101

Accounts payable

(648

(1,226

Deferred revenue

4,254

1,823

Other liabilities

(200

400

Cash generated by operating activities

7,049

5,301

Investing Activities:

Purchases of marketable securities

(34,696

(17,153

Proceeds from maturities of marketable securities

12,780

9,378

Proceeds from sales of marketable securities

9,117

2,367

Purchases of other long-term investments

(61

(31

Payment for acquisition of property, plant and equipment

(685

(688

Payment for acquisition of intangible assets

(56

(89

Other

(62

20

Cash used in investing activities

(13,663

(6,196

Financing Activities:

Proceeds from issuance of common stock

288

411

Excess tax benefits from stock-based compensation

124

621

Cash used to net share settle equity awards

(68

(116

Cash generated by financing activities

344

916

(Decrease)/Increase in cash and cash equivalents

(6,270

21

Cash and cash equivalents, end of the period

5,605

9,373

Supplemental cash flow disclosure:

Cash paid for income taxes, net

2,490

1,022

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting

Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) design, manufacture,

and market personal computers, portable digital music players, and mobile communication devices and sell a variety of related software, third-party digital content and applications, services, peripherals, and networking solutions. The Company sells

its products worldwide through its online stores, its retail stores, its direct sales force, and third-party wholesalers, resellers, and value-added resellers. In addition, the Company sells a variety of third-party Mac, iPod, and iPhone compatible

products including application software, printers, storage devices, speakers, headphones, and various other accessories and supplies through its online and retail stores. The Company sells to consumer, small and mid-sized business ( SMB ),

education, enterprise, government, and creative markets.

Basis of Presentation and Preparation

The accompanying Condensed Consolidated Financial Statements include the accounts of the Company. Intercompany accounts and transactions have been

eliminated. The accompanying Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary to present fairly the Condensed Consolidated Financial

Statements for all periods presented. The preparation of these Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts

reported in these Condensed Consolidated Financial Statements and accompanying notes. Actual results could differ materially from those estimates.

Certain prior year amounts in the Condensed Consolidated Financial Statements and notes thereto have been reclassified to conform to the current period s presentation. During the first quarter of 2009, the Company reclassified

$2.4 billion of certain fixed-income securities from short-term marketable securities to long-term marketable securities in the September 27, 2008 Condensed Consolidated Balance Sheet. The reclassification resulted from a change in

accounting presentation for certain investments based on contractual maturity dates, which more closely reflects the Company s assessment of the timing of when such securities will be converted to cash. As a result of this change, marketable

securities with maturities less than 12 months are classified as short-term and marketable securities with maturities greater than 12 months are classified as long-term. There have been no changes in the Company s investment policies or

practices associated with this change in accounting presentation. See Note 2, Financial Instruments of this Form 10-Q for additional information.

These Condensed Consolidated Financial Statements and accompanying notes should be read in conjunction with the Company s annual Consolidated Financial Statements and the notes thereto for the fiscal year ended

September 27, 2008, included in its Annual Report on Form 10-K (the 2008 Form 10-K ). Unless otherwise stated, references to particular years or quarters refer to the Company s fiscal years ended in September and the associated

quarters of those fiscal years.

In May 2009, the Financial Accounting Standards Board ( FASB ) issued Statement of Financial

Accounting Standards ( SFAS ) No. 165, Subsequent Events, which established general accounting standards and disclosure for subsequent events. The Company adopted SFAS No. 165 during the third quarter of 2009. In

accordance with SFAS No. 165, the Company has evaluated subsequent events through the date and time the financial statements were issued on July 22, 2009.

Earnings Per Common Share

Basic earnings per common share is computed by dividing income available

to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares

of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include

outstanding options, shares to be purchased under the employee stock purchase plan, and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by

application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table sets forth the computation of basic and diluted earnings per common share for the

three- and nine-month periods ended June 27, 2009 and June 28, 2008 (in thousands, except net income in millions and per share amounts):

Three Months Ended

Nine Months Ended

June 27,

2009

June 28,

2008

June 27,

2009

June 28,

2008

Numerator:

Net income

1,229

1,072

4,039

3,698

Denominator:

Weighted-average shares outstanding

893,712

883,738

891,345

879,753

Effect of dilutive securities

15,448

19,429

13,204

21,275

Weighted-average shares diluted

909,160

903,167

904,549

901,028

Basic earnings per common share

1.38

1.21

4.53

4.20

Diluted earnings per common share

1.35

1.19

4.47

4.10

Potentially dilutive securities representing approximately 10.5 million and 8.4 million

shares of common stock for the three months ended June 27, 2009 and June 28, 2008, respectively, and 13.4 million and 9.2 million shares of common stock for the nine months ended June 27, 2009 and June 28, 2008,

respectively, were excluded from the computation of diluted earnings per common share for these periods because their effect would have been antidilutive.

Fair Value Measurements

During the third quarter of 2009, the Company adopted FASB Staff Position ( FSP )

No. 107 and Accounting Principles Board ( APB ) 28-1, Disclosures about Fair Value of Financial Instruments, which requires disclosure about fair value of financial instruments in interim and annual financial statements. The

adoption of FSP No. 107 and APB 28-1 had no financial impact on the Company s Condensed Consolidated Financial Statements.

During the first quarter of 2009, the Company adopted SFAS No. 157, Fair Value Measurements, which defines fair value, establishes guidelines for measuring fair value and expands disclosures regarding fair value measurements.

SFAS No. 157 does not require any new fair value measurements, but rather eliminates inconsistencies in guidance found in various other accounting pronouncements. The adoption of SFAS No. 157 did not have a material effect on the

Company s financial condition or operating results.

SFAS No. 157 establishes a hierarchy for information and valuations used in

measuring fair value, which is broken down into three levels. Level 1 valuations are based on quoted prices in active markets for identical assets or liabilities. Level 2 valuations are based on inputs that are observable, either directly or

indirectly, other than quoted prices included within Level 1. Level 3 valuations are based on information that is unobservable and significant to the overall fair value measurement.

The Company also adopted SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities including an amendment of FASB Statement No. 115, during the

first quarter of 2009. SFAS No. 159 allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. SFAS No. 159 requires that unrealized

gains and losses on items for which the fair value option has been elected be reported in earnings at each reporting date. The Company adopted SFAS No. 159 but has not elected the fair value option for any eligible financial instruments.

Refer to Note 3, Fair Value Measurements of this Form 10-Q for additional information on the adoption of FSP No. 107 and

SFAS Nos. 157 and 159.

Financial Instruments

During the third quarter of 2009, the Company adopted FSP No. FAS 115-2 and FAS 124-2, Recognition and Presentation of Other-Than-Temporary Impairments, which provide operational guidance

for determining other-than-temporary impairments for debt securities. The adoption of FSP No. FAS 115-2 and FAS 124-2 did not have a material effect on the Company s financial condition or operating results.

During the second quarter of 2009, the Company adopted SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities an

amendment of FASB Statement No. 133, which requires additional disclosures about the Company s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for under

SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities, and related interpretations, and how the derivative instruments and related hedged items affect the financial statements. The adoption of SFAS No. 161 had

no financial impact on the Company s Condensed Consolidated Financial Statements.

Refer to Note 2, Financial Instruments

of this Form 10-Q for additional information on the adoption of FSP No. FAS 115-2 and FAS 124-2 and SFAS No. 161.

Note 2 Financial

Instruments

Cash, Cash Equivalents and Marketable Securities

The following table summarizes the fair value of the Company s cash and available-for-sale securities held in its marketable securities investment portfolio, recorded as cash, cash equivalents, short-term or

long-term marketable securities as of June 27, 2009 and September 27, 2008 (in millions):

June 27, 2009

September 27, 2008

Cash

871

368

Money market funds

2,601

1,536

U.S. Treasury securities

262

118

U.S. agency securities

510

2,798

Certificates of deposit and time deposits

554

2,560

Commercial paper

789

4,429

Corporate securities

66

Municipal securities

18

Total cash equivalents

4,734

11,507

U.S. Treasury securities

2,951

343

U.S. agency securities

12,083

5,823

Non-U.S. government securities

110

83

Certificates of deposit and time deposits

247

486

Commercial paper

1,116

1,254

Corporate securities

2,020

2,247

Municipal securities

90

Total short-term marketable securities

18,617

10,236

U.S. Treasury securities

428

100

U.S. agency securities

1,266

751

Non-U.S. government securities

74

Certificates of deposit and time deposits

32

Corporate securities

4,833

1,496

Municipal securities

298

Total long-term marketable securities

6,899

2,379

Total cash, cash equivalents and marketable securities

31,121

24,490

As of December 27, 2008, the Company changed its accounting presentation for certain fixed-income

investments, which resulted in the reclassification of certain investments from short-term marketable securities to long-term marketable securities. As a result, prior period balances have been reclassified to conform to the current period s

presentation. The Company classifies its marketable securities as either short-term or long-term based on each instrument s underlying contractual maturity date, while its prior classifications were based on the nature of the securities and

their availability for use in current operations. As a result of this change, marketable securities with maturities of less than 12 months are classified as short-term and marketable securities with maturities greater than 12 months are classified

as long-term. The Company s long-term marketable securities maturities range from one year to five years. The Company believes this new presentation is preferable as it more closely reflects the Company s assessment of the timing of

when such securities will be converted to cash. Accordingly, certain fixed-income investments totaling $2.4 billion have been reclassified from short-term marketable securities to long-term marketable securities in the September 27, 2008

Condensed Consolidated Balance Sheet to conform to the current period s financial statement presentation. There have been no changes in the Company s investment policies or practices associated with this change in accounting presentation.

The following tables summarize the Company s available-for-sale securities adjusted cost, gross unrealized gains, gross

unrealized losses and fair value by significant investment category as of June 27, 2009 and September 27, 2008 (in millions):

June 27, 2009

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Money market funds

2,601

2,601

U.S. Treasury securities

3,637

3,641

U.S. agency securities

13,828

31

13,859

Non-U.S. government securities

185

(1

184

Certificates of deposit and time deposits

801

801

Commercial paper

1,905

1,905

Corporate securities

6,868

29

(44

6,853

Municipal securities

405

406

Total cash equivalents and marketable securities

30,230

65

(45

30,250

September 27, 2008

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Money market funds

1,536

1,536

U.S. Treasury securities

559

561

U.S. agency securities

9,383

(13

9,372

Non-U.S. government securities

83

83

Certificates of deposit and time deposits

3,078

3,078

Commercial paper

5,683

5,683

Corporate securities

3,917

(108

3,809

Total cash equivalents and marketable securities

24,239

(121

24,122

The Company had net unrealized gains on its investment portfolio of $20 million as of

June 27, 2009 and net unrealized losses on its investment portfolio of $117 million as of September 27, 2008. The net unrealized gains as of June 27, 2009 related primarily to short-term marketable securities, while the net unrealized

losses as of September 27, 2008 related primarily to long-term marketable securities. The Company may sell certain of its

marketable securities prior to their stated maturities for strategic purposes, in anticipation of credit deterioration, or for duration management. The

Company recognized no material net gains or losses during the three- and nine-month periods ended June 27, 2009 and June 28, 2008 related to such sales.

The following table shows the gross unrealized losses and fair value for investments in an unrealized loss position as of June 27, 2009 and September 27, 2008, aggregated by investment category and the

length of time that individual securities have been in a continuous loss position (in millions):

June 27, 2009

Less than 12 Months

12 Months or Greater

Total

Security Description

Fair

Value

Unrealized

Losses

Fair

Value

Unrealized

Losses

Fair

Value

Unrealized

Loss

Non-U.S. government securities

125

(1

125

(1

Corporate securities

1,084

(3

1,033

(41

2,117

(44

Total

1,209

(4

1,033

(41

2,242

(45

September 27, 2008

Less than 12 Months

12 Months or Greater

Total

Security Description

Fair

Value

Unrealized

Losses

Fair

Value

Unrealized

Losses

Fair

Value

Unrealized

Loss

U.S. agency securities

6,822

(13

6,822

(13

Corporate securities

2,147

(31

1,148

(77

3,295

(108

Total

8,969

(44

1,148

(77

10,117

(121

The Company considers the declines in market value of its marketable securities investment

portfolio to be temporary in nature. The unrealized losses on the Company s marketable securities were caused primarily by changes in market interest rates, specifically, widening credit spreads. The Company typically invests in highly-rated

securities, and its policy generally limits the amount of credit exposure to any one issuer. The Company s investment policy requires investments to be rated single-A or better, with the objective of minimizing the potential risk of principal

loss. Fair values were determined for each individual security in the investment portfolio. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value

has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company s intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the

investment s amortized cost basis. During the three- and nine-month periods ended June 27, 2009 and June 28, 2008, the Company did not recognize any material impairment charges on outstanding securities. As of June 27, 2009, the

Company does not consider any of its investments to be other-than-temporarily impaired.

Derivative Financial Instruments

The Company uses derivatives to partially offset its business exposure to foreign exchange risk. The Company may enter into foreign currency forward and

option contracts to offset some of the foreign exchange risk of expected future cash flows on certain forecasted revenue and cost of sales, of net investments in certain foreign subsidiaries, and on certain existing assets and liabilities. To help

protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose functional currency is the U.S. dollar, hedge a portion of forecasted foreign currency revenue. The Company s

subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies, may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges

portions of its forecasted foreign currency exposure associated with revenue and inventory purchases for three to six months. To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the

Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. The Company may also enter into foreign currency forward

and option contracts to partially offset the foreign exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign

exchange exposures for a variety of reasons, including but not limited to immateriality, accounting

considerations, and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of

the financial impact resulting from movements in foreign exchange rates. As of the end of the third quarter of 2009, the general nature of the Company s risk management activities and the general nature and mix of the Company s derivative

financial instruments have not changed materially from the end of 2008.

The Company s accounting policies for these instruments are

based on whether the instruments are designated as hedge or non-hedge instruments in accordance with SFAS No. 133. The Company records all derivatives on the balance sheet at fair value. The effective portions of cash flow hedges are recorded

in other comprehensive income until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. Derivatives that are not

designated as hedging instruments and the ineffective portions of cash flow hedges and net investment hedges are adjusted to fair value through earnings in other income and expense.

The Company had a net deferred gain associated with cash flow hedges of approximately $37 million and $19 million, net of taxes, recorded in other comprehensive income as of June 27, 2009

and September 27, 2008, respectively. Other comprehensive income associated with cash flow hedges of foreign currency revenue is recognized as a component of net sales in the same period as the related revenue is recognized, and other

comprehensive income related to cash flow hedges of inventory purchases is recognized as a component of cost of sales in the same period as the related costs are recognized. The portion of the Company s net deferred gain related to products

under subscription accounting is expected to be recorded in earnings ratably over the related products estimated economic lives beginning when the hedged transactions occur, while the portion of the net deferred gain related to other products

is expected to be recorded in earnings at the time the hedged transactions occur. As of June 27, 2009, the hedged transactions are expected to occur within six months.

Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period

or within a subsequent two month time period. Deferred gains and losses in other comprehensive income associated with such derivative instruments are reclassified immediately into earnings through other income and expense. Any subsequent changes in

fair value of such derivative instruments also are reflected in current earnings unless they are re-designated as hedges of other transactions. The Company did not recognize any material net gains related to the loss of hedge designation on

discontinued cash flow hedges during the three- and nine-month periods ended June 27, 2009 and June 28, 2008, respectively.

The

Company had an unrealized net loss on net investment hedges of $6 million and $1 million, net of taxes, included in the cumulative translation adjustment account of accumulated other comprehensive income ( AOCI ) as of June 27, 2009

and September 27, 2008, respectively. The ineffective portions and amounts excluded from the effectiveness test of net investment hedges are recorded in current earnings in other income and expense.

The Company recognized in earnings a net loss of $34 million and a net gain of $139 million on foreign currency forward and option contracts not

designated as hedging instruments in accordance with SFAS No. 133 during the three- and nine-month periods ended June 27, 2009, respectively.

The following table shows the notional principal and credit risk amounts of the Company s derivative instruments outstanding as of June 27, 2009 (in millions):

June 27, 2009

Notional

Principal

Credit Risk

Amounts

Instruments qualifying as accounting hedges:

Foreign exchange contracts

2,927

23

Instruments other than accounting hedges:

Foreign exchange contracts

6,540

41

10

The notional principal amounts for derivative instruments provide one measure of the transaction volume

outstanding as of June 27, 2009, and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on these transactions if

all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates. The Company s exposure to credit loss and market risk will vary over time as a function of currency exchange rates.

Although the table above reflects the notional principal and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions that the foreign exchange

instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of

the instruments.

The estimates of fair value are based on applicable and commonly used pricing models and prevailing financial market

information as of June 27, 2009. Refer to Note 3, Fair Value Measurements of this Form 10-Q, for additional information on the fair value measurements for all financial assets and liabilities, including derivative assets and

derivative liabilities, that are measured at fair value in the Condensed Consolidated Financial Statements on a recurring basis. The following table shows the Company s derivative instruments measured at gross fair value as reflected in the

Condensed Consolidated Balance Sheet as of June 27, 2009 (in millions):

June 27, 2009

Fair Value of

Derivatives Designated

as Hedge Instruments

Fair Value of Derivatives

Not Designated as Hedge

Instruments

Derivative assets (a):

Foreign exchange contracts

22

41

Derivative liabilities (b):

Foreign exchange contracts

29

37

(a)

All derivative assets are recorded as other current assets in the Condensed Consolidated Balance Sheets.

(b)

All derivative liabilities are recorded as accrued expenses in the Condensed Consolidated Balance Sheets.

The following tables show the effect of the Company s derivative instruments designated as cash flow and net investment hedges in the Condensed

Consolidated Statements of Operations for the three- and nine-month periods ended June 27, 2009 (in millions):

Three Months Ended June 27, 2009

Gain or (Loss)

Recognized in

AOCI -

Effective

Portion (a)

Location of

Gain or (Loss)

Reclassified

from AOCI into

Income

Effective

Portion

Gain or (Loss)

Reclassified

from AOCI

into Income -

Effective

Portion (a)

Location of Gain

or (Loss)

Recognized -

Ineffective

Portion

and

Amount Excluded

from

Effectiveness

Testing

Gain or (Loss)

Recognized -

Ineffective Portion

and Amount

Excluded

from

Effectiveness

Testing

Cash flow hedges:

Foreign exchange contracts

(13

Net sales

12

Other income

and expense

(13